Pharmaceutical company Wockhardt on Friday announced that the company has entered into an agreement with Enso Healthcare DMCC (Enso), a company incorporated in Dubai, UAE and Human Vaccine LLC (HV), a wholly owned subsidiary of the sovereign wealth fund of the Russian Federation (RDIF), for the manufacture and supply of the Sputnik V/Sputnik Light vaccine against Covid-19.
‘’Subject to requisite approvals and other conditions, upon successful technology transfer from HV to the company, the company will manufacture and supply to Enso up to 620 million doses of the Sputnik V vaccine and the Sputnik Light vaccine against Covid-19,” Wockhardt said in a statement.
The agreement between the Company, HV, Enso was reached under the aegis of Enso, RDIF’s coordinating partner for sourcing Sputnik vaccine in India.
